Peter Gregory

Publications

• Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Veterans Affairs Cooperative Variceal Sclerotherapy Group. Hartigan PM, Gebhard RL, Gregory PB. Gastrointest Endosc. 1997; 46 (1): 1-7
• Gregory P and the Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic Sclerotherapy for Esophageal Varices in Men with Alcoholic Liver Disease: A Randomized, Single-blind, Multicenter Clinical Trial. Gregory P, Veterans Affairs Cooperative Variceal Sclerotherapy Group. New England Journal of Medicine. 1991: 324 1779-184
• Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance. Lai CL, Gregory PB, Wu PC, Lok AS, Wong KP, Ng MM. Cancer. 1987; 60 (5): 1107-10
• Survival in chronic hepatitis B. An analysis of 379 patients. Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB. Ann Intern Med. 1984; 101 (5): 613-6
• Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. Smith CI, Kitchen LW, Scullard GH, Robinson WS, Gregory PB, Merigan TC. JAMA. 1982; 247 (16): 2261-5
• Diuresis in the ascitic patient: a randomized controlled trial of three regimens. Fogel MR, Sawhney VK, Neal EA, Miller RG, Knauer CM, Gregory PB. J Clin Gastroenterol. 1981: 3 Suppl 1 73-80
• Upper gastrointestinal bleeding. Accuracy of clinical diagnosis and prognosis. Gregory PB, Knauer CM, Fogel MR, Andres LL, Rinki MM, Walker JE. Dig Dis Sci. 1981; 26 (7 Suppl): 65S-69S
• Complications of diuresis in the alcoholic patient with ascites: a controlled trial. Gregory PB, Broekelschen PH, Hill MD, Lipton AB, Knauer CM, Egger M, Miller R. Gastroenterology. 1977; 73 (3): 534-8
• Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC. N Engl J Med. 1976; 295 (10): 517-22
• Steroid therapy in severe viral hepatitis. A double-blind, randomized trial of methyl-prednisolone versus placebo. Gregory PB, Knauer CM, Kempson RL, Miller R. N Engl J Med. 1976; 294 (13): 681-7
• Spleen shielding in survivors of the atomic bomb. Gregory PB, Milton RC, Johnson ML, Taura T. Radiat Res. 1968; 33 (2): 204-15
• Limitations of liver surface US in the diagnosis of cirrhosis. Ladenheim JA, Luba DG, Yao F, Gregory PB, Jeffrey RB, Garcia G. Radiology. 1992; 185 (1): 21-3; discussion 23-4
• Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state. Garcia G, Smedile A, Bergmann KF, Gerin JL, Gregory PB, Merigan TC, Robinson WS. West J Med. 1990; 153 (1): 80-2
• Interferon in chronic hepatitis B. Gregory PB, Gastroenterology. 1986; 90 (1): 237-40
• Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection. Eisenberg M, Rosno S, Garcia G, Konrad MW, Gregory PB, Robinson WS, Merigan TC. Antimicrob Agents Chemother. 1986; 29 (1): 122-6
• Antivirals in chronic hepatitis B--problems of small clinical trials. Gregory PB, Gastroenterology. 1984; 86 (1): 201-4
• High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasma. Smith GA, Giacomini KM, Smith CT, Gregory PB, Robinson WS, Merigan TC, Blaschke TF. J Chromatogr. 1984; 307 (2): 410-5
• Measurement of attenuation and scatterer spacing in human liver tissue: preliminary results. Sommer FG, Gregory PB, Fellingham LL, Stern RA, Nassi M, Weissberg J, Solomon H. J Ultrasound Med. 1984; 3 (12): 557-61
• Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection. Smith CI, Weissberg J, Bernhardt L, Gregory PB, Robinson WS, Merigan TC. J Infect Dis. 1983; 148 (5): 907-13
• Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study. Stein DT, Gray GM, Gregory PB, Anderson M, Goodwin DA, McDougall IR. Gastroenterology. 1983; 84 (2): 388-93
• Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatment. Scullard GH, Greenberg HB, Smith JL, Gregory PB, Merigan TC, Robinson WS. Hepatology. 1982 Jan-Feb; 2 (1): 39-49
• Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination. Sacks SL, Scullard GH, Pollard RB, Gregory PB, Robinson WS, Merigan TC. Antimicrob Agents Chemother. 1982; 21 (1): 93-100
• Continuous intravenous vasopressin in active upper gastrointestinal bleeding. Fogel MR, Knauer CM, Andres LL, Mahal AS, Stein DE, Kemeny MJ, Rinki MM, Walker JE, Siegmund D, Gregory PB. Ann Intern Med. 1982; 96 (5): 565-9
• Lymphomas involving the gastrointestinal tract. Gray GM, Rosenberg SA, Cooper AD, Gregory PB, Stein DT, Herzenberg H. Gastroenterology. 1982; 82 (1): 143-52
• Preliminary studies of acyclovir in chronic hepatitis B. Smith CI, Scullard GH, Gregory PB, Robinson WS, Merigan TC. Am J Med. 1982; 73 (1A): 267-70
• Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver disease. Andres LL, Sawhney VK, Scullard GH, Smith JL, Merigan TC, Robinson WS, Gregory PB. Hepatology. 1981 Nov-Dec; 1 (6): 583-5
• Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Scullard GH, Andres LL, Greenberg HB, Smith JL, Sawhney VK, Neal EA, Mahal AS, Popper H, Merigan TC, Robinson WS, Gregory PB. Hepatology. 1981 May-Jun; 1 (3): 228-32
• Hepatitis B viral markers in severe viral hepatitis: influence of steroid therapy. Greenberg HB, Robinson WS, Knauer CM, Gregory PB. Hepatology. 1981 Jan-Feb; 1 (1): 54-7
• Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. Scullard GH, Pollard RB, Smith JL, Sacks SL, Gregory PB, Robinson WS, Merigan TC. J Infect Dis. 1981; 143 (6): 772-83
• Bleeding after liver biopsy. Mahal AS, Knauer CM, Gregory PB. West J Med. 1981; 134 (1): 11-4
• Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Gastroenterology. 1981; 81 (6): 987-91
• Furosemide disposition in cirrhotic patients. Sawhney VK, Gregory PB, Swezey SE, Blaschke TF. Gastroenterology. 1981; 81 (6): 1012-6
• Halothane hepatitis in three pairs of closely related women. Hoft RH, Bunker JP, Goodman HI, Gregory PB. N Engl J Med. 1981; 304 (17): 1023-4
• The demise of corticosteroid therapy for acute viral hepatitis. Gregory PB, Gastroenterology. 1981; 80 (2): 404-6
• Interferon in chronic hepatitis B infection. Merigan TC, Robinson WS, Gregory PB. Lancet. 1980; 1 (8165): 422-3
• Rapid reduction of transaminase levels in fulminant hepatitis. Sawhey VK, Knauer CM, Gregory PB. N Engl J Med. 1980; 302 (17): 970
• Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis. Neal EA, Meffin PJ, Gregory PB, Blaschke TF. Gastroenterology. 1979; 77 (1): 96-102
• Effect of vidarabine on chronic hepatitis B virus infection. Pollard RB, Smith JL, Neal A, Gregory PB, Merigan TC, Robinson WS. JAMA. 1978; 239 (16): 1648-50
• The treatment of ascites. Gregory PB, Ration Drug Ther. 1978; 12 (7): 1-4
• A refractory case of hepatic amoebiasis. Gregory PB, Gastroenterology. 1976; 70 (4): 585-8
• Corticosteroid treatment of hepatitis. Gregory PB, N Engl J Med. 1976; 295 (23): 1322
• Misleading SGOT (aspartate aminotransferase) values in obstructive jaundice due to pancreatic carcinoma. Gregory PB, Cooney DP. Am J Dig Dis. 1976; 21 (6): 509-11
• Liver function in survivors of the atomic bomb. Gregory PB, Amamoto K, Archer PG, Rickert RR, Omori Y, Bizzozero OJ, Hamilton HB, Johnson KG. Radiat Res. 1975; 63 (3): 578-83
• Splenomegaly in uncomplicated biliary tract and pancreatic disease. Gregory PB, Klatskin G. Gastroenterology. 1972; 62 (3): 436-40
• Renal tuberculosis in the Japanese. Gregory PB, Seki M, Sawada H, Johnson KG. J Chronic Dis. 1967; 20 (4): 225-31
• ETIOCHOLANOLONE FEVER. BONDY PK, COHN GL, GREGORY PB. Medicine (Baltimore). 1965: 44 249-62